Can aripiprazole augmentation therapy be discontinued in patients with major depressive disorder in remission? A placebo-controlled, double-blind, comparative study

Masahiro Takeshima

[JP9-2] Can aripiprazole augmentation therapy be discontinued in patients with major depressive disorder in remission? A placebo-controlled, double-blind, comparative study

*Masahiro Takeshima¹, Akise Umakoshi¹, Yoshizawa Kazuhisa¹, Masaya Ogasawara¹, Yu Itoh¹, Kazuo Mishima¹ (1. Department of Neuropsychiatry, Akita University Graduate School of Medicine)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Presentation information

臨床研究④

[JP9-2] Can aripiprazole augmentation therapy be discontinued in patients with major depressive disorder in remission? A placebo-controlled, double-blind, comparative study

Password